7/19/2013

Par Pharmaceutical obtained federal approval for its fenofibric acid delayed-release capsules in two strengths to curb triglycerides and boost levels of high-density lipoprotein cholesterol. The drug is a generic copy of AbbVie's Trilipix.

Full Story:
Drug Store News

Related Summaries